of 2006, the Advisory Committee on immunization practices (ACIP) voted to recommend that the first vaccine developed to prevent cervical cancer and other diseases in women caused by the human papillovirus such as genital warts be approved for public use. (The ACIP is a division of the Centers for Disease Control And Prevention. Members of the ACIP are national experts who advise the CDC).

The vaccine, called Gardasil, is a product of t

Genital warts are caused by the human papillomavirus. There are more than 100 HPVs that affect humans and 40 of these can cause infections of the genital tract and anus of men and women.

A subgroup of the HPVs that infect the anogenital tract (genital tract and anus) can cause precancerous changes in the uterine cervix and may cause uterine or cervical cancer. Genital warts and HPV are spread by sexual intimacy, and the risk of infection increases as the number of sexual partners increases.

The virus that causes genital warts is transmitted by direct genital contact during sexual activity. The virus is not found in or spread by bodily fluids, and HPV is not found in blood or organs harvested for transplantation. Condom use seems to decrease the risk of transmission of HPV during sexual activity but does not completely prevent HPV infection. Spermicides and hormonal birth control methods cannot prevent the spread of HPV infection.

Both people with HPV infection and their partners need to be counseled about the risk of spreading HPV .They should understand that the absence of lesions does not exclude the possibility of transmission and that condoms are not completely effective in preventing the spread of the infection.

Finally, female partners of men with genital warts should be reminded of the importance of regular Pap smears to screen for cervical cancer and precancerous changes in the cervix, since precancerous changes can be treated and reduce a woman’s risk of developing cervical cancer.

Since HPV is the known cause of genital warts, there has been considerable research conducted about the development of a vaccine to prevent HPV. There is some new research that offers hope of prevention of genital warts in women. In June of 2006, the Advisory Committee on immunization practices (ACIP) voted to recommend that the first vaccine developed to prevent cervical cancer and other diseases in women caused by the human papillovirus such as genital warts be approved for public use. (The ACIP is a division of the Centers for Disease Control And Prevention. Members of the ACIP are national experts who advise the CDC).

The vaccine, called Gardasil, is a product of th

n increases as the number of sexual partners increases.

The virus that causes genital warts is transmitted by direct genital contact during sexual activity. The virus is not found in or spread by bodily fluids, and HPV is not found in blood or organs harvested for transplantation. Condom use seems to decrease the risk of transmission of HPV during sexual activity but does not completely prevent HPV infection. Spermicides and hormonal birth control methods cannot prevent the spread of HPV infection.

Both people with HPV infection and their partners need to be counseled about the risk of spreading HPV .They should understand that the absence of lesions does not exclude the possibility of transmission and that condoms are not completely effective in preventing the spread of the infection.

Finally, female partners of men with genital warts should be reminded of the importance of regular Pap smears to screen for cervical cancer and precancerous changes in the cervix, since precancerous changes can be treated and reduce a woman’s risk of developing cervical cancer.

Since HPV is the known cause of genital warts, there has been considerable research conducted about the development of a vaccine to prevent HPV. There is some new research that offers hope of prevention of genital warts in women. In June of 2006, the Advisory Committee on immunization practices (ACIP) voted to recommend that the first vaccine developed to prevent cervical cancer and other diseases in women caused by the human papillovirus such as genital warts be approved for public use. (The ACIP is a division of the Centers for Disease Control And Prevention. Members of the ACIP are national experts who advise the CDC).

The vaccine, called Gardasil, is a product of t

rth control methods cannot prevent the spread of HPV infection.

Both people with HPV infection and their partners need to be counseled about the risk of spreading HPV .They should understand that the absence of lesions does not exclude the possibility of transmission and that condoms are not completely effective in preventing the spread of the infection.

Finally, female partners of men with genital warts should be reminded of the importance of regular Pap smears to screen for cervical cancer and precancerous changes in the cervix, since precancerous changes can be treated and reduce a woman’s risk of developing cervical cancer.

Since HPV is the known cause of genital warts, there has been considerable research conducted about the development of a vaccine to prevent HPV. There is some new research that offers hope of prevention of genital warts in women. In June of 2006, the Advisory Committee on immunization practices (ACIP) voted to recommend that the first vaccine developed to prevent cervical cancer and other diseases in women caused by the human papillovirus such as genital warts be approved for public use. (The ACIP is a division of the Centers for Disease Control And Prevention. Members of the ACIP are national experts who advise the CDC).

The vaccine, called Gardasil, is a product of t

mportance of regular Pap smears to screen for cervical cancer and precancerous changes in the cervix, since precancerous changes can be treated and reduce a woman’s risk of developing cervical cancer.

Since HPV is the known cause of genital warts, there has been considerable research conducted about the development of a vaccine to prevent HPV. There is some new research that offers hope of prevention of genital warts in women. In June of 2006, the Advisory Committee on immunization practices (ACIP) voted to recommend that the first vaccine developed to prevent cervical cancer and other diseases in women caused by the human papillovirus such as genital warts be approved for public use. (The ACIP is a division of the Centers for Disease Control And Prevention. Members of the ACIP are national experts who advise the CDC).

The vaccine, called Gardasil, is a product of t

of 2006, the Advisory Committee on immunization practices (ACIP) voted to recommend that the first vaccine developed to prevent cervical cancer and other diseases in women caused by the human papillovirus such as genital warts be approved for public use. (The ACIP is a division of the Centers for Disease Control And Prevention. Members of the ACIP are national experts who advise the CDC).

The vaccine, called Gardasil, is a product of the latest research on genital warts and can protect against four HPV types, which together cause 70 percent of cervical cancer and 90 percent of genital warts. Because of this latest research on genital warts, the Food and Drug Administration (FDA) recently licensed this vaccine for use in girls and women from nine to 26 years of age. There is heated political debate about whether or not this vaccine should be mandatory for all young girls.

Since HPV is the known cause of genital warts, it is hoped that a similar vaccine will be developed for men in the near future. In the meantime, safe sex practices are recommended for people with genital warts since the virus that causes genital warts is transmitted through intimate contact.

Glossary:
Human papillomavirus: The virus that causes genital warts Gardasil: A vaccine that has been approved for use by the FDA in the prevention of genital warts.